Acadia Pharmaceuticals (ACAD) Tax Rate (2017 - 2026)

Acadia Pharmaceuticals' Tax Rate history runs 10 years deep, the most recent figure standing at 7.54% for Q1 2026.

• On a quarterly basis, Tax Rate fell 2409.0% year-over-year to 7.54% in Q1 2026; TTM through Mar 2026 was 28.99%, a 3287.0% decrease from a year earlier, with the FY2025 full-year figure at 17.87%, down 2018.0% from the prior year.
• Tax Rate advanced to 7.54% in Q1 2026 per ACAD's latest filing, from 76.11% in the prior quarter.
• Across five years, Tax Rate topped out at 82.44% in Q2 2023 and bottomed at 76.11% in Q4 2025.
• The 5-year median for Tax Rate is 0.43% (2022), against an average of 1.01%.
• Across the five-year window, Tax Rate jumped 8376 bps in 2023 and sank 7653 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 1.96% in 2022, then tumbled by 679 bps to 15.25% in 2023, then jumped by 66 bps to 5.18% in 2024, then slumped by 1370 bps to 76.11% in 2025, then surged by 110 bps to 7.54% in 2026.
• Per Business Quant, the three latest ACAD Tax Rate figures stand at 7.54% (Q1 2026), 76.11% (Q4 2025), and 60.96% (Q3 2025).